[325] suggested that TET1 has a tumor suppressor effect in ovarian cancer because TET1 inhibits typical Wnt/β‐catenin signaling by activating the signaling inhibitors DKK and secreted Fzd receptor protein 2, which suppresses EMT and metastasis of the cancer cells. Here, TET1 is linked to neoplasm.